NORTHWEST BIOTHERAPEUTICS IN's ticker is and the CUSIP is 66737P900. A total of 1 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $38,000 | -47.2% | 65,700 | +32.5% | 0.00% | – |
| Q1 2016 | $72,000 | -43.8% | 49,600 | +24.3% | 0.00% | – |
| Q4 2015 | $128,000 | -80.2% | 39,900 | -61.4% | 0.00% | -100.0% |
| Q3 2015 | $646,000 | -65.9% | 103,300 | -45.8% | 0.00% | -50.0% |
| Q2 2015 | $1,893,000 | +88.0% | 190,600 | +39.5% | 0.00% | +100.0% |
| Q1 2015 | $1,007,000 | +98.6% | 136,600 | +44.2% | 0.00% | – |
| Q4 2014 | $507,000 | +57.5% | 94,700 | +48.0% | 0.00% | – |
| Q3 2014 | $322,000 | -64.5% | 64,000 | -52.6% | 0.00% | -100.0% |
| Q2 2014 | $906,000 | +106.8% | 135,000 | +123.1% | 0.00% | 0.0% |
| Q1 2014 | $438,000 | – | 60,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 64,000 | $322,000 | 0.00% |